Video Experimental Relacionado
Updated: Feb 15, 2026
06:36
Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue
Published on: May 1, 2019
7.5K
Avances en la investigación de la inmunoterapia para el cáncer gástrico con subtipos moleculares específicos
1The First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou 730030, China Department of General Surgery, the 940th Hospital of Joint Logistics Support Force of People's Liberation Army, Lanzhou 730050, China.
Resumen
La inmunoterapia ofrece una nueva esperanza para el tratamiento del cáncer gástrico en diversas etapas. Esta revisión destaca los avances en inhibidores de puntos de control inmunitario y otras terapias adaptadas a subtipos moleculares específicos como el cáncer gástrico HER2-positivo y EBV-positivo.
Área de la Ciencia:
- Oncología
- Inmunología
- Gastroenterología
Sus antecedentes:
- El cáncer gástrico es una de las principales causas de mortalidad relacionada con el cáncer en todo el mundo.
- La inmunoterapia ha surgido como una modalidad de tratamiento fundamental para el cáncer gástrico, que afecta a los entornos neoadyuvante, de conversión y adyuvante.
- Los avances recientes incluyen inhibidores de puntos de control inmunitario, terapia celular adoptiva y vacunas antitumorales.
Objetivo del estudio:
- Revisar el progreso reciente de la investigación en inmunoterapia para el cáncer gástrico.
- Centrarse en las estrategias de inmunoterapia para subtipos moleculares específicos de cáncer gástrico.
- Proporcionar información para enfoques de tratamiento personalizados y precisos basados en subtipos moleculares y estadios clínicos.
Principales métodos:
- Revisión de la literatura sobre la investigación reciente en inmunoterapia para el cáncer gástrico.
- Análisis de la eficacia de la inmunoterapia en diferentes subtipos moleculares: HER2-positivo, Claudin18.2-positivo, dMMR/MSI-H, EBV-positivo y AFP-positivo.
- Síntesis de los hallazgos para informar estrategias de tratamiento personalizadas.
Principales resultados:
- La inmunoterapia ha transformado significativamente el panorama del tratamiento del cáncer gástrico.
- Las inmunoterapias específicas muestran promesa en subtipos molecularmente definidos de cáncer gástrico.
- Los enfoques de inmunoterapia adaptados son cruciales para optimizar los resultados de los pacientes.
Conclusiones:
- Las estrategias personalizadas de inmunoterapia son esenciales para mejorar la eficacia del tratamiento en el cáncer gástrico.
- La comprensión de los subtipos moleculares es clave para desarrollar intervenciones terapéuticas precisas.
- La investigación continua en inmunoterapia tiene un potencial significativo para avanzar en la atención del cáncer gástrico.
Videos de Conceptos Relacionados
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
01:16Gastric Motility
3.3K
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
3.3K
01:16Gastric Emptying
4.0K
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
4.0K
01:31Adrenergic Receptors: ɑ Subtype
3.0K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.0K
01:26Adrenergic Receptors: β Subtype
3.9K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.9K
01:26Gastric Phase of Digestion
3.6K
The gastric phase of digestion begins as soon as food enters the stomach. The incoming food bolus triggers neural and hormonal mechanisms, which last approximately 3 to 4 hours. During this phase, the stomach undergoes significant changes to prepare the food for further digestion and absorption.
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
3.6K